Back to Journals » Infection and Drug Resistance » Volume 13

Serum Concentration of Vancomycin Is a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Septic Patients in Clinical and Surgical Wards

Authors Zamoner W, Gonçalves Pierri I, Zanchetta Cardoso Eid K, Maria Bellaver de Almeida L, dos Santos A, Luís Balbi A, Ponce D

Received 19 June 2019

Accepted for publication 9 January 2020

Published 10 February 2020 Volume 2020:13 Pages 403—411


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Eric Nulens

Welder Zamoner,1 Isabella Gonçalves Pierri,1 Karina Zanchetta Cardoso Eid,1 Lais Maria Bellaver de Almeida,1 Adriano dos Santos,2 André Luís Balbi,1 Daniela Ponce1

1Botucatu School of Medicine, São Paulo State University - UNESP, Botucatu, São Paulo, Brazil; 2Clinics Hospital Pharmacy, Botucatu School of Medicine, Botucatu, São Paulo 18618-970, Brazil

Correspondence: Welder Zamoner Tel +55 14 9821 72334

Introduction and Aim: There have been few studies to evaluate the monitoring of plasmatic concentrations of vancomycin in septic patients and their association with acute kidney injury (AKI) and death. This study aimed to evaluate the prevalence of adequate, subtherapeutic, and toxic serum concentrations of vancomycin in hospitalized septic patients and to associate the adequacy of therapeutic monitoring with clinical outcomes.
Methodology: This was a cohort-unicentric study that evaluated septic patients aged > 18 years using vancomycin admitted to clinical and surgical wards of a Brazilian university center from August 2016 to July 2017 in a daily and uninterrupted way. We excluded patients with AKI prior to the introduction of vancomycin or with AKI development < 48 hours after use, patients with AKI of other etiologies, stage V chronic kidney disease, and pregnant women.
Results: We evaluated 225 patients, and 135 were included. Evaluation of serum concentration of vancomycin was realized in 94.1%, and of those, 59.3% presented toxic concentrations. The prevalence of AKI was 27.4% and happened on average on the ninth day of vancomycin usage. Between the fourth and sixth days, vancomycin serum concentration of > 21.5 mg/L was a predictor of AKI, with area under the curve of 0.803 (95% CI 0.62– 0.98, p=0.005), preceding the diagnosis of AKI by at least 3 days. Of these patients, 20.7% died, and serum concentrations of vancomycin between the fourth and sixth days were identified as risk factors associated with negative outcomes.
Conclusion: Serum concentration of vancomycin is an excellent predictor of AKI in patients admitted to wards, preceding the diagnosis of AKI by at least 72 hours. Toxic concentrations of vancomycin are associated with AKI, and AKI was a risk factor for death. Also, serum concentration of vancomycin > 21.5 mg/L was the only variable associated with death in the Cox model.

Keywords: sepsis, acute kidney injury, vancomycin, nephrotoxicity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]